Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
ProGenis Pharmaceuticals Logo
ProGenis Pharmaceuticals Growth Score
49
CB Rank
168124
Heat Score
43
ProGenis Pharmaceuticals is a biotechnology firm specializing in precision RNA medicines.
Founded
obfuscation
PrivateGrant Bentley, Western Australia, Australia11-50 progenispharma.com
Manufacturing
Pharmaceutical
Therapeutics
Overview

ProGenis Pharmaceuticals
Total Funding
obfuscation
Growth Score
49
Heat Score
43

Total Funding
obfuscation
obfuscation
Grant raised
obfuscation
Growth Score49
-14 pts
in past quarter
Heat Score 43
-12 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About ProGenis Pharmaceuticals

CB Rank
168124
ProGenis Pharmaceuticals is a biotechnology firm specializing in precision RNA medicines.
Founded
obfuscation
PrivateGrant Bentley, Western Australia, Australia11-50 progenispharma.com
Manufacturing
Pharmaceutical
Therapeutics

Funding Rounds

Grant
OBF
in
obfuscation
Grant
OBF
in
obfuscation

Details

Operating Status Active
Company Type For Profit
About the Company
ProGenis Pharmaceuticals is a biotechnology firm specializing in precision RNA medicines targeted at inherited and acquired rare diseases as well as type 2 diabetes, multiple sclerosis, Duchenne muscular dystrophy, and Rett syndrome.
Predictions & Insights

Growth Insight

See this Growth Insight
ProGenis Pharmaceuticals is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Runway Speculation

Products & Services

Splice Switching Antisense Oligonucleotide Drugs
RNA-based therapeutics designed to modify RNA splicing to treat inherited rare and acquired diseases.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - ProGenis Pharmaceuticals Logo
Grant - ProGenis Pharmaceuticals
1
obfuscation
Future Health Research and InnovationGrant
obfuscation
Grant - ProGenis Pharmaceuticals Logo
Grant - ProGenis Pharmaceuticals
1
obfuscation
Future Health Research and InnovationGrant
obfuscation
Grant - ProGenis Pharmaceuticals Logo
Grant - ProGenis Pharmaceuticals
1
obfuscation
Future Health Research and InnovationGrant
obfuscation
Grant - ProGenis Pharmaceuticals Logo
Grant - ProGenis Pharmaceuticals
1
obfuscation
Future Health Research and InnovationGrant
obfuscation
Grant - ProGenis Pharmaceuticals Logo
Grant - ProGenis Pharmaceuticals
1
obfuscation
Future Health Research and InnovationGrant

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - ProGenis Pharmaceuticals Logo
Grant - ProGenis Pharmaceuticals
1
obfuscation
Future Health Research and InnovationGrant
obfuscation
Grant - ProGenis Pharmaceuticals Logo
Grant - ProGenis Pharmaceuticals
1
obfuscation
Future Health Research and InnovationGrant
obfuscation
Grant - ProGenis Pharmaceuticals Logo
Grant - ProGenis Pharmaceuticals
1
obfuscation
Future Health Research and InnovationGrant
obfuscation
Grant - ProGenis Pharmaceuticals Logo
Grant - ProGenis Pharmaceuticals
1
obfuscation
Future Health Research and InnovationGrant
obfuscation
Grant - ProGenis Pharmaceuticals Logo
Grant - ProGenis Pharmaceuticals
1
obfuscation
Future Health Research and InnovationGrant

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 11-50
News

News and Press

News•Nov 19, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

533
887.04%
 in past month

Active Website Tech Count

6ProGenis Pharmaceuticals is actively using 6 technologies for its website, according to BuiltWith. These include Common Crawl, DNSSEC, and  CommonCrawl Top 10m.
Sub-Organizations
Frequently Asked Questions

Where is ProGenis Pharmaceuticals's headquarters? ProGenis Pharmaceuticals is located in Bentley, Western Australia, Australia.Who invested in ProGenis Pharmaceuticals? ProGenis Pharmaceuticals has 2 investors including Future Health Research and Innovation and  MTPConnect.When was the last funding round for ProGenis Pharmaceuticals? ProGenis Pharmaceuticals closed its last funding round on
obfuscation
from a Grant round.Who are ProGenis Pharmaceuticals's competitors? Alternatives and possible competitors to ProGenis Pharmaceuticals may include Alnylam Pharmaceuticals, Entrada Therapeutics, and  Pepgen.How much funding has ProGenis Pharmaceuticals raised to date? ProGenis Pharmaceuticals has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(05b78c5 1)
|